Endocrine tumors of the uterine cervix: Incidence, demographics, and survival with comparison to squamous cell carcinoma

Gynecologic Oncology

Volumn 88, Issue 3, 2003, Pages 333-339

  McCusker, Margaret E ^a,d   Coté, Timothy R ^b,e   Clegg, Limin X ^b   Tavassoli, Fattaneh J ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^d TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Cervix; Endocrine tumors; Epidemiology; Incidence; Neuroendocrine carcinoma; SEER; Squamous cell carcinoma; Survival

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; ENDOCRINE TUMOR; HAZARD; HUMAN; HUMAN CELL; LYMPH NODE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 0037339480     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(02)00150-6     Document Type: Article

References (28)

1. Pazdur R., Bonomi P., Slayton R., Gould V.E., Miller A., Jao W., et al. Neuroendocrine carcinoma of the cervix implications for staging and therapy . Gynecol Oncol. 12:1981;120-128.
2. Tateishi R., Wada A., Hayakawa K., Hongo J., Ishii S., Terakawa N. Argyrophil cell carcinomas (Apudomas) of the uterine cervix light and electron microscopic observations of 5 cases . Virchows Arch A Pathol Anat Histol. 366:1975;257-274.
3. Barrett R.J., Davos I., Leuchter R.S., Lagasse L.D. Neuroendocrine features in poorly differentiated and undifferentiated carcinomas of the cervix. Cancer. 60:1987;2325-2330.
4. Ueda G., Shimizu C., Shimizu H., Saito J., Tanaka Y., Inoue M., et al. An immunohistochemical study of small-cell and poorly differentiated carcinomas of the cervix using neuroendocrine markers. Gynecol Oncol. 34:1989;164-169.
5. Sheets E.E., Berman M.L., Hrountas C.K., Liao S.Y., DiSaia P.J. Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol. 71:1988;10-14.
6. Gilks C.B., Young R.H., Gersell D.J., Clement P.B. Large cell carcinoma of the uterine cervix a clinicopathologic study of 12 cases . Am J Surg Pathol. 21:1997;905-914.
7. Tsou M.-H., Tan T.-D., Cheng S., Chiuo Y.-K. Small cell carcinoma of the uterine cervix with large cell neuroendocrine component. Gynecol Oncol. 68:1998;69-72.
8. Chang T.-C., Lai C.-H., Tseng C.-J., Hsueh S., Huang K.-G., Chou H.-H. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer. 83:1998;712-718.
9. Boruta D.M., Schorge J.O., Duska L.A., Crum C.P., Castrillon D.H., Sheets E.E. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Gynecol Oncol. 81:2001;82-87. (doi:101006/gyno.2000.6118).
10. Rhemtula H., Grayson W., van Iddekinge B., Tiltman A. Large-cell neuroendocrine carcinoma of the uterine cervix - a clinicopathological study of five cases. S Afr Med J. 91:2001;525-528.
11. Albores-Saavedra J., Larraza O., Poucell S., Rodriguez Martinez H.A. Carcinoid of the uterine cervix additional observations on a new tumor entity . Cancer. 38:1976;2328-2342.
12. Albores-Saavedra J., Gersell D., Gilks B., Henson D.E., Lindberg G., Santiago H., et al. Terminology of endocrine tumors of the uterine cervix results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute . Arch Pathol Lab Med. 121:1997;34-39.
13. Stoler M.H., Mills S.E., Gersell D.J., Walker A.N. Small-cell neuroendocrine carcinoma of the cervix a human papillomavirus type 18-associated cancer . Am J Surg Pathol. 15:1991;28-32.
14. Abeler V.M., Holm R., Nesland J.M., Kjostad K.E. Small cell carcinoma of the cervix a clinicopathologic study of 26 patients . Cancer. 73:1994;672-677.
15. Mannion C., Park W.-S., Man Y.G., Zhuang Z., Albores-Saavedra J., Tavassoli F.A. Endocrine tumors of the cervix morphologic assessment, expression of human papillomavirus, and evaluation for loss of heterozygosity on 1p, 3p, 11q, and 17p . Cancer. 83:1998;1391-1400.
16. Herrington C.S., Graham D., Southern S.A., Bramdev A., Chetty R. Loss of retinoblastoma protein expression is frequent in small cell neuroendocrine carcinoma of the cervix and is unrelated to HPV type. Hum Pathol. 30:1999;906-910.
17. Witsuba I.I., Thomas B., Behrens C., Onuki N., Lindberg G., Albores-Saavedra J., et al. Molecular abnormalities associated with endocrine tumors of the uterine cervix. Gynecol Oncol. 72:1999;3-9. (doi:gyno1998.5248).
18. Yun K., Cho N.-P., Glassford G.N. Large cell neuroendocrine carcinoma of the uterine cervix a report of a case with coexisting cervical intraepithelial neoplasia and human papillomavirus 16 . Pathology. 31:1999;158-161.
19. Crum C.P. The molecular biology of neuroendocrine cervical carcinoma are we witnessing early or late events? Gynecol Oncol. 72:1999;1-2. (doi:gyno1998.5313).
20. Ries L.A.G., Eisner M.P., Kosary C.L., et al. SEER cancer statistics review, 1973-1998. 2001;National Cancer Institute, Bethesda, MD. (http://seer.cancer.gov/ Publications/CSR1973_1998/).
21. National Cancer Institute. About SEER ( http://seer.cancer.gov/AboutSEER.html ).
22. Surveillance, Epidemiology, and End-Results (SEER) program. Public-use data (1973-1998). Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program. Released April 2001, based on August 2000 submission.
23. Pecorelli S., Benedet J.L., Creasman W.T., Shepard J.H. FIGO staging of gynecologic cancer 1994-1997 FIGO committee on gynecologic oncology. International Federation of Gynecology and Obstetrics . Int J Gynecol Obstet. 64:1999;5-10.
24. Percy C., Van Holten V., Muir C. International classification of diseases for oncology (ICD-O). 2nd edition: 1990;World Health Organization, Geneva.
25. Percy C., VanHolten V. International classification of diseases for oncology field trial edition 1986 . 1986;World Health Organization, Geneva.
26. Liu S., Semenciw R., Probert A., Mao Y. Cervical cancer in Canada changing patterns in incidence and mortality . Int J Gynecol Cancer. 11:2001;24-31.
27. Bergstrom R., Sparen P., Adami H.O. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer. 81:1999;159-166.
28. Vizcaino A.P., Moreno V., Bosch F.X., Munoz N., Barros-Dios X.M., Borras J., et al. International trends in incidence of cervical cancer II. Squamous-cell carcinoma . Int J Cancer. 86:2000;429-435.